Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Randomization Period	STARTED	Mavacamten	56
Randomization Period	STARTED	Placebo to Mavacamten	56
Randomization Period	COMPLETED	Mavacamten	56
Randomization Period	COMPLETED	Placebo to Mavacamten	55
Randomization Period	NOT COMPLETED	Mavacamten	0
Randomization Period	NOT COMPLETED	Placebo to Mavacamten	1
Double Blind Treatment Period	STARTED	Mavacamten	56
Double Blind Treatment Period	STARTED	Placebo to Mavacamten	55
Double Blind Treatment Period	COMPLETED	Mavacamten	52
Double Blind Treatment Period	COMPLETED	Placebo to Mavacamten	45
Double Blind Treatment Period	NOT COMPLETED	Mavacamten	4
Double Blind Treatment Period	NOT COMPLETED	Placebo to Mavacamten	10
Long Term Follow up	STARTED	Mavacamten	56
Long Term Follow up	STARTED	Placebo to Mavacamten	52
Long Term Follow up	COMPLETED	Mavacamten	51
Long Term Follow up	COMPLETED	Placebo to Mavacamten	42
Long Term Follow up	NOT COMPLETED	Mavacamten	5
Long Term Follow up	NOT COMPLETED	Placebo to Mavacamten	10

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04349072/flow